Pages that link to "Q38280297"
Jump to navigation
Jump to search
The following pages link to Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? (Q38280297):
Displaying 50 items.
- Chemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspective (Q26777967) (← links)
- Mechanisms involved in the development of chemotherapy-induced neuropathy (Q26824380) (← links)
- Vincristine-induced peripheral neuropathy in pediatric cancer patients (Q28078232) (← links)
- Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review (Q28270819) (← links)
- Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression (Q28468568) (← links)
- Intravenous Lidocaine: Old-School Drug, New Purpose-Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral Neuropathy (Q33552212) (← links)
- Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. (Q33744706) (← links)
- [EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect? (Q33824948) (← links)
- Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo (Q35903899) (← links)
- Complex impairment of IA muscle proprioceptors following traumatic or neurotoxic injury (Q35911716) (← links)
- Mutations in the Heme Exporter FLVCR1 Cause Sensory Neurodegeneration with Loss of Pain Perception (Q36214268) (← links)
- New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy (Q36226275) (← links)
- Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin-induced neuropathic cold hypersensitivity (Q36648880) (← links)
- The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective (Q36992406) (← links)
- Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain (Q37082177) (← links)
- Cancer and orofacial pain. (Q37423829) (← links)
- A Hyperresponsive HPA Axis May Confer Resilience Against Persistent Paclitaxel-Induced Mechanical Hypersensitivity (Q37526640) (← links)
- A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy (Q37582203) (← links)
- Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives. (Q38522262) (← links)
- Cancer and Referred Facial Pain (Q38531548) (← links)
- Melatonin Attenuates Pain Hypersensitivity and Decreases Astrocyte-Mediated Spinal Neuroinflammation in a Rat Model of Oxaliplatin-Induced Pain (Q38622694) (← links)
- Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain. (Q38697158) (← links)
- Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy. (Q38719679) (← links)
- Functional vitamin B12 deficiency in advanced malignancy: implications for the management of neuropathy and neuropathic pain (Q38785132) (← links)
- Vascular endothelial growth factor: a neurovascular target in neurological diseases (Q38882640) (← links)
- The use of antioxidant agents for chemotherapy-induced peripheral neuropathy treatment in animal models (Q39397982) (← links)
- Ninjin'yoeito and ginseng extract prevent oxaliplatin-induced neurodegeneration in PC12 cells (Q40154379) (← links)
- Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms (Q41078635) (← links)
- Platinum-induced neurotoxicity: A review of possible mechanisms (Q41374593) (← links)
- Cisplatin induced sensory neuropathy is prevented by vascular endothelial growth factor-A. (Q41949087) (← links)
- Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy (Q42361415) (← links)
- Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity (Q42361420) (← links)
- Anti-allodynic effect of theoesberiven F in a vincristine-induced neuropathy model. (Q42413541) (← links)
- Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights (Q42705208) (← links)
- Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse (Q45053532) (← links)
- Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN). (Q45356332) (← links)
- The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells. (Q46097844) (← links)
- Cisplatin induces mitochondrial deficits in Drosophila larval segmental nerve. (Q46472909) (← links)
- Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN). (Q46719997) (← links)
- Quetiapine reverses paclitaxel-induced neuropathic pain in mice: Role of alpha2- adrenergic receptors (Q47115156) (← links)
- Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia. (Q47177557) (← links)
- Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia. (Q47310338) (← links)
- OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity. (Q47558946) (← links)
- Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. (Q47599462) (← links)
- Effect of ninjin'yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice (Q47976693) (← links)
- The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy. (Q48214395) (← links)
- Myelin development, plasticity, and pathology in the auditory system. (Q48325621) (← links)
- Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. (Q48706983) (← links)
- New perspectives for a well-known biogenic amine: mast cell-derived histamine as pathophysiological agent in vincristine-induced neuropathic pain (Q50002918) (← links)
- Neuropathic Pain: Delving into the Oxidative Origin and the Possible Implication of Transient Receptor Potential Channels (Q50319836) (← links)